{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:04:31Z","timestamp":1793840671815,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82388201"],"award-info":[{"award-number":["82388201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071764"],"award-info":[{"award-number":["82071764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC2304502"],"award-info":[{"award-number":["2022YFC2304502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-025-00695-3","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T06:41:34Z","timestamp":1743835294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Chronic hepatitis B virus infection imbalances short-chain fatty acids and amino acids in the liver and gut via microbiota modulation"],"prefix":"10.1186","volume":"17","author":[{"given":"Wendi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"11","key":"695_CR1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21(11):719\u201333.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"695_CR2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s11427-017-9128-3","volume":"60","author":"X Wu","year":"2017","unstructured":"Wu X, Tian Z. Gut-liver axis: gut microbiota in shaping hepatic innate immunity. Sci China Life Sci. 2017;60(11):1191\u20136.","journal-title":"Sci China Life Sci"},{"issue":"43","key":"695_CR3","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.3748\/wjg.v27.i43.7446","volume":"27","author":"MA Neag","year":"2021","unstructured":"Neag MA, Mitre AO, Catinean A, Buzoianu AD. Overview of the microbiota in the gut-liver axis in viral B and C hepatitis. World J Gastroenterol. 2021;27(43):7446\u201361.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"695_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hep.27791","volume":"62","author":"X Wu","year":"2015","unstructured":"Wu X, Sun R, Chen Y, Zheng X, Bai L, Lian Z, Wei H, Tian Z. Oral ampicillin inhibits liver regeneration by breaking hepatic innate immune tolerance normally maintained by gut commensal bacteria. Hepatology. 2015;62(1):253\u201364.","journal-title":"Hepatology"},{"key":"695_CR5","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1038\/ncomms13839","volume":"7","author":"F Li","year":"2017","unstructured":"Li F, Hao X, Chen Y, Bai L, Gao X, Lian Z, Wei H, Sun R, Tian Z. The microbiota maintain homeostasis of liver-resident gammadeltaT-17 cells in a lipid antigen\/CD1d-dependent manner. Nat Commun. 2017;7:13839.","journal-title":"Nat Commun"},{"key":"695_CR6","doi-asserted-by":"crossref","first-page":"1119875","DOI":"10.3389\/fcimb.2023.1119875","volume":"13","author":"X Yang","year":"2023","unstructured":"Yang X, Mai H, Zhou J, Li Z, Wang Q, Lan L, Lu F, Yang X, Guo B, Ye L, et al. Alterations of the gut microbiota associated with the occurrence and progression of viral hepatitis. Front Cell Infect Microbiol. 2023;13:1119875.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"695_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.21037\/hbsn-20-270","volume":"10","author":"S Sookoian","year":"2021","unstructured":"Sookoian S, Pirola CJ. Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactions. Hepatobiliary Surg Nutr. 2021;10(3):337\u201349.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"8","key":"695_CR8","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/gutjnl-2019-318811","volume":"69","author":"S Sookoian","year":"2020","unstructured":"Sookoian S, Salatino A, Castano GO, Landa MS, Fijalkowky C, Garaycoechea M, Pirola CJ. Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease. Gut. 2020;69(8):1483\u201391.","journal-title":"Gut"},{"issue":"7","key":"695_CR9","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1073\/pnas.1424775112","volume":"112","author":"HH Chou","year":"2015","unstructured":"Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, Ni YH, Tseng HT, Wu D, Lu X, et al. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA. 2015;112(7):2175\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"695_CR10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.tim.2015.04.001","volume":"23","author":"B Wang","year":"2015","unstructured":"Wang B, Li L. Who determines the outcomes of HBV exposure? Trends Microbiol. 2015;23(6):328\u20139.","journal-title":"Trends Microbiol"},{"key":"695_CR11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fimmu.2019.00927","volume":"10","author":"T Wu","year":"2019","unstructured":"Wu T, Li F, Chen Y, Wei H, Tian Z, Sun C, Sun R. CD4(+) T cells play a critical role in microbiota-maintained anti-HBV immunity in a mouse model. Front Immunol. 2019;10:927.","journal-title":"Front Immunol"},{"key":"695_CR12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fcimb.2019.00377","volume":"9","author":"Q Zhu","year":"2019","unstructured":"Zhu Q, Xia P, Zhou X, Li X, Guo W, Zhu B, Zheng X, Wang B, Yang D, Wang J. Hepatitis B virus infection alters gut microbiota composition in mice. Front Cell Infect Microbiol. 2019;9:377.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"695_CR13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00248-010-9801-8","volume":"61","author":"H Lu","year":"2011","unstructured":"Lu H, Wu Z, Xu W, Yang J, Chen Y, Li L. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection Intestinal microbiota of HBV cirrhotic patients. Microb Ecol. 2011;61(3):693\u2013703.","journal-title":"Microb Ecol"},{"issue":"2","key":"695_CR14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00248-011-9925-5","volume":"63","author":"M Xu","year":"2012","unstructured":"Xu M, Wang B, Fu Y, Chen Y, Yang F, Lu H, Chen Y, Xu J, Li L. Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease. Microb Ecol. 2012;63(2):304\u201313.","journal-title":"Microb Ecol"},{"issue":"4","key":"695_CR15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhin.2017.04.007","volume":"96","author":"Y Kang","year":"2017","unstructured":"Kang Y, Cai Y. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy. J Hosp Infect. 2017;96(4):342\u20138.","journal-title":"J Hosp Infect"},{"issue":"5","key":"695_CR16","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/hep.29008","volume":"65","author":"YD Ren","year":"2017","unstructured":"Ren YD, Ye ZS, Yang LZ, Jin LX, Wei WJ, Deng YY, Chen XX, Xiao CX, Yu XF, Xu HZ, et al. Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy. Hepatology. 2017;65(5):1765\u20138.","journal-title":"Hepatology"},{"issue":"1","key":"695_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0029665120006916","volume":"80","author":"C Martin-Gallausiaux","year":"2021","unstructured":"Martin-Gallausiaux C, Marinelli L, Blottiere HM, Larraufie P, Lapaque N. SCFA: mechanisms and functional importance in the gut. Proc Nutr Soc. 2021;80(1):37\u201349.","journal-title":"Proc Nutr Soc"},{"issue":"5","key":"695_CR18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neo.2021.04.004","volume":"23","author":"N McBrearty","year":"2021","unstructured":"McBrearty N, Arzumanyan A, Bichenkov E, Merali S, Merali C, Feitelson M. Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice. Neoplasia. 2021;23(5):529\u201338.","journal-title":"Neoplasia"},{"issue":"1","key":"695_CR19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41423-019-0330-1","volume":"18","author":"X Hao","year":"2021","unstructured":"Hao X, Chen Y, Bai L, Wei H, Sun R, Tian Z. HBsAg-specific CD8(+) T cells as an indispensable trigger to induce murine hepatocellular carcinoma. Cell Mol Immunol. 2021;18(1):128\u201337.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"695_CR20","doi-asserted-by":"crossref","first-page":"G1044","DOI":"10.1152\/ajpgi.00184.2004","volume":"287","author":"B Jaruga","year":"2004","unstructured":"Jaruga B, Hong F, Kim WH, Gao B. IFN-gamma\/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol. 2004;287(5):G1044-1052.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"695_CR21","doi-asserted-by":"crossref","first-page":"G84","DOI":"10.1152\/ajpgi.00118.2019","volume":"318","author":"SAM Albhaisi","year":"2020","unstructured":"Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. Am J Physiol Gastrointest Liver Physiol. 2020;318(1):G84\u201398.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"695_CR22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fmicb.2020.00383","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Xie Y, Zhou F, Zhang B, Wu J, Yang L, Xu S, Stedtfeld R, Chen Q, Liu J, et al. Featured gut microbiomes associated with the progression of chronic hepatitis B disease. Front Microbiol. 2020;11:383.","journal-title":"Front Microbiol"},{"issue":"1","key":"695_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13099-023-00549-w","volume":"15","author":"MJ Lin","year":"2023","unstructured":"Lin MJ, Su TH, Chen CC, Wu WK, Hsu SJ, Tseng TC, Liao SH, Hong CM, Yang HC, Liu CJ, et al. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease. Gut Pathog. 2023;15(1):24.","journal-title":"Gut Pathog"},{"key":"695_CR24","doi-asserted-by":"crossref","first-page":"1152987","DOI":"10.3389\/fcimb.2023.1152987","volume":"13","author":"F Yan","year":"2023","unstructured":"Yan F, Zhang Q, Shi K, Zhang Y, Zhu B, Bi Y, Wang X. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response. Front Cell Infect Microbiol. 2023;13:1152987.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"695_CR25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13099-021-00461-1","volume":"13","author":"EJ Joo","year":"2021","unstructured":"Joo EJ, Cheong HS, Kwon MJ, Sohn W, Kim HN, Cho YK. Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B. Gut Pathog. 2021;13(1):65.","journal-title":"Gut Pathog"},{"issue":"1","key":"695_CR26","doi-asserted-by":"crossref","first-page":"15138","DOI":"10.1038\/s41598-023-42312-w","volume":"13","author":"K He","year":"2023","unstructured":"He K, Liu M, Wang Q, Chen S, Guo X. Combined analysis of 16S rDNA sequencing and metabolomics to find biomarkers of drug-induced liver injury. Sci Rep. 2023;13(1):15138.","journal-title":"Sci Rep"},{"issue":"3","key":"695_CR27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247798","volume":"16","author":"M Saab","year":"2021","unstructured":"Saab M, Mestivier D, Sohrabi M, Rodriguez C, Khonsari MR, Faraji A, Sobhani I. Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma. PLoS ONE. 2021;16(3): e0247798.","journal-title":"PLoS ONE"},{"issue":"1","key":"695_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12876-024-03129-7","volume":"24","author":"M Thing","year":"2024","unstructured":"Thing M, Werge MP, Kimer N, Hetland LE, Rashu EB, Nabilou P, Junker AE, Galsgaard ED, Bendtsen F, Laupsa-Borge J, et al. Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease. BMC Gastroenterol. 2024;24(1):43.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"695_CR29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1165\/rcmb.2021-0515OC","volume":"67","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang L, Mao L, Fan J, Jiang X, Li N, Fan Y, Jiang Z, Qin X, Qiu F, et al. Intestinal microbiota-derived propionic acid protects against zinc oxide nanoparticle-induced lung injury. Am J Respir Cell Mol Biol. 2022;67(6):680\u201394.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"695_CR30","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1111\/cas.15983","volume":"114","author":"C Zheng","year":"2023","unstructured":"Zheng C, Lu F, Chen B, Yang J, Yu H, Wang D, Xie H, Chen K, Xie Y, Li J, et al. Gut microbiome as a biomarker for predicting early recurrence of HBV-related hepatocellular carcinoma. Cancer Sci. 2023;114(12):4717\u201331.","journal-title":"Cancer Sci"},{"key":"695_CR31","volume":"239","author":"X Ye","year":"2024","unstructured":"Ye X, He X, Hu Z, Zheng F, Huang X, Xie X, Chen F, Ou H, Qiu R. Metabolomic analysis identifies dysregulation of lipid metabolism in the immune clearance phase of chronic hepatitis B patients. J Pharm Biomed Anal. 2024;239: 115900.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"695_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00075197-200303000-00013","volume":"6","author":"Z Zhong","year":"2003","unstructured":"Zhong Z, Wheeler MD, Li X, Froh M, Schemmer P, Yin M, Bunzendaul H, Bradford B, Lemasters JJ. L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care. 2003;6(2):229\u201340.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"695_CR33","doi-asserted-by":"crossref","first-page":"1716701","DOI":"10.1155\/2017\/1716701","volume":"2017","author":"MA Razak","year":"2017","unstructured":"Razak MA, Begum PS, Viswanath B, Rajagopal S. Multifarious beneficial effect of nonessential amino acid, glycine: a review. Oxid Med Cell Longev. 2017;2017:1716701.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"695_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1389557516666160609081602","volume":"17","author":"I Perez-Torres","year":"2017","unstructured":"Perez-Torres I, Zuniga-Munoz AM, Guarner-Lans V. Beneficial effects of the amino acid glycine. Mini Rev Med Chem. 2017;17(1):15\u201332.","journal-title":"Mini Rev Med Chem"},{"issue":"6","key":"695_CR35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00726-019-02722-5","volume":"51","author":"M Al-Saeedi","year":"2019","unstructured":"Al-Saeedi M, Liang R, Schultze DP, Nickkholgh A, Herr I, Zorn M, Schemmer P. Glycine protects partial liver grafts from Kupffer cell-dependent ischemia-reperfusion injury without negative effect on regeneration. Amino Acids. 2019;51(6):903\u201311.","journal-title":"Amino Acids"},{"issue":"2","key":"695_CR36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/hep.26668","volume":"59","author":"L Xu","year":"2014","unstructured":"Xu L, Yin W, Sun R, Wei H, Tian Z. Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in hepatitis B virus-persistent mice. Hepatology. 2014;59(2):443\u201352.","journal-title":"Hepatology"},{"issue":"4","key":"695_CR37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.17219\/acem\/62759","volume":"26","author":"F Yuan","year":"2017","unstructured":"Yuan F, Zhang W, Mu D, Gong J. Kupffer cells in immune activation and tolerance toward HBV\/HCV infection. Adv Clin Exp Med. 2017;26(4):739\u201345.","journal-title":"Adv Clin Exp Med"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00695-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00695-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00695-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:39:01Z","timestamp":1744216741000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-025-00695-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00695-3","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree with the publication of the manuscript to Gut Pathogens.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}